Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Germany), Germany, covering academic research published from 2006 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
51
Total Open
Publications
25
Total
Citations
1.4K
Open Access
Percentage
49%
Total
Publications
51
Total Open
Publications
25
Total
Citations
1.4K
Breakdown
Publisher Open
18%
Both
25%
Other Platform Open
6%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
5
Hybrid 59%
13
No Guarantees 18%
4
Other Platform Open
Institution 50%
8
Domain 50%
8
Other Internet 13%
2
Public 6%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 8 |
DANS - Data Archiving and Networked Services | Institution | 2 |
Unknown Repository | Other Internet | 1 |
University of Bristol - Bristol Research | Institution | 1 |
Universidade Federal de São Paulo - UNIFESP Institutional Repository | Institution | 1 |
TESEO - Consultation of the Doctoral Thesis Database | Institution | 1 |
Servicio Gallego de Salud (SERGAS - RUNA. Repositorio Institucional del Sergas) | Institution | 1 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 1 |
Konstfack University of Arts, Crafts, and Design - Publications | Institution | 1 |
Figshare | Public | 1 |